nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—Transaminases increased—Carmustine—malignant glioma	0.018	0.0279	CcSEcCtD
Olmesartan—Influenza-like symptoms—Temozolomide—malignant glioma	0.0148	0.023	CcSEcCtD
Olmesartan—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.0129	0.02	CcSEcCtD
Olmesartan—Telmisartan—PPARG—malignant glioma	0.0124	0.457	CrCbGaD
Olmesartan—Viral infection—Temozolomide—malignant glioma	0.0117	0.0182	CcSEcCtD
Olmesartan—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.0117	0.0181	CcSEcCtD
Olmesartan—Hepatic enzyme increased—Temozolomide—malignant glioma	0.0112	0.0174	CcSEcCtD
Olmesartan—Influenza like illness—Temozolomide—malignant glioma	0.0103	0.0159	CcSEcCtD
Olmesartan—Aplastic anaemia—Temozolomide—malignant glioma	0.00995	0.0154	CcSEcCtD
Olmesartan—Diabetes mellitus—Carmustine—malignant glioma	0.00916	0.0142	CcSEcCtD
Olmesartan—Gastroenteritis—Temozolomide—malignant glioma	0.00868	0.0134	CcSEcCtD
Olmesartan—Injury—Carmustine—malignant glioma	0.00867	0.0134	CcSEcCtD
Olmesartan—Hyponatraemia—Carmustine—malignant glioma	0.008	0.0124	CcSEcCtD
Olmesartan—Face oedema—Carmustine—malignant glioma	0.00769	0.0119	CcSEcCtD
Olmesartan—Face oedema—Temozolomide—malignant glioma	0.00743	0.0115	CcSEcCtD
Olmesartan—Candesartan—PTGS1—malignant glioma	0.00736	0.272	CrCbGaD
Olmesartan—Irbesartan—PTGS1—malignant glioma	0.00736	0.272	CrCbGaD
Olmesartan—Hypokalaemia—Carmustine—malignant glioma	0.00725	0.0112	CcSEcCtD
Olmesartan—Hypokalaemia—Temozolomide—malignant glioma	0.007	0.0108	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00693	0.0107	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00693	0.0107	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00679	0.0105	CcSEcCtD
Olmesartan—Pancytopenia—Carmustine—malignant glioma	0.00654	0.0101	CcSEcCtD
Olmesartan—Neutropenia—Carmustine—malignant glioma	0.00644	0.00997	CcSEcCtD
Olmesartan—Bronchitis—Temozolomide—malignant glioma	0.0064	0.00991	CcSEcCtD
Olmesartan—Pancytopenia—Temozolomide—malignant glioma	0.00632	0.00978	CcSEcCtD
Olmesartan—Neutropenia—Temozolomide—malignant glioma	0.00622	0.00963	CcSEcCtD
Olmesartan—Hyperglycaemia—Carmustine—malignant glioma	0.00621	0.00962	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00618	0.00957	CcSEcCtD
Olmesartan—Pneumonia—Carmustine—malignant glioma	0.00617	0.00956	CcSEcCtD
Olmesartan—Erectile dysfunction—Temozolomide—malignant glioma	0.00613	0.00949	CcSEcCtD
Olmesartan—Photosensitivity reaction—Temozolomide—malignant glioma	0.00607	0.0094	CcSEcCtD
Olmesartan—Renal failure—Carmustine—malignant glioma	0.00603	0.00934	CcSEcCtD
Olmesartan—Hyperglycaemia—Temozolomide—malignant glioma	0.006	0.00929	CcSEcCtD
Olmesartan—Urinary tract infection—Carmustine—malignant glioma	0.00597	0.00924	CcSEcCtD
Olmesartan—Pneumonia—Temozolomide—malignant glioma	0.00597	0.00924	CcSEcCtD
Olmesartan—Infestation NOS—Temozolomide—malignant glioma	0.00593	0.00918	CcSEcCtD
Olmesartan—Infestation—Temozolomide—malignant glioma	0.00593	0.00918	CcSEcCtD
Olmesartan—Urinary tract infection—Temozolomide—malignant glioma	0.00577	0.00893	CcSEcCtD
Olmesartan—Sinusitis—Temozolomide—malignant glioma	0.00556	0.00862	CcSEcCtD
Olmesartan—Oedema peripheral—Carmustine—malignant glioma	0.00543	0.0084	CcSEcCtD
Olmesartan—Connective tissue disorder—Carmustine—malignant glioma	0.00541	0.00838	CcSEcCtD
Olmesartan—Pharyngitis—Temozolomide—malignant glioma	0.00528	0.00818	CcSEcCtD
Olmesartan—Urinary tract disorder—Temozolomide—malignant glioma	0.00526	0.00814	CcSEcCtD
Olmesartan—Oedema peripheral—Temozolomide—malignant glioma	0.00525	0.00812	CcSEcCtD
Olmesartan—Connective tissue disorder—Temozolomide—malignant glioma	0.00523	0.0081	CcSEcCtD
Olmesartan—Urethral disorder—Temozolomide—malignant glioma	0.00522	0.00808	CcSEcCtD
Olmesartan—Arrhythmia—Carmustine—malignant glioma	0.00492	0.00762	CcSEcCtD
Olmesartan—Alopecia—Carmustine—malignant glioma	0.00487	0.00754	CcSEcCtD
Olmesartan—Angiopathy—Temozolomide—malignant glioma	0.00483	0.00748	CcSEcCtD
Olmesartan—Mental disorder—Carmustine—malignant glioma	0.00483	0.00747	CcSEcCtD
Olmesartan—Mediastinal disorder—Temozolomide—malignant glioma	0.0048	0.00743	CcSEcCtD
Olmesartan—Malnutrition—Carmustine—malignant glioma	0.0048	0.00743	CcSEcCtD
Olmesartan—Alopecia—Temozolomide—malignant glioma	0.00471	0.00729	CcSEcCtD
Olmesartan—Mental disorder—Temozolomide—malignant glioma	0.00466	0.00722	CcSEcCtD
Olmesartan—Back pain—Carmustine—malignant glioma	0.00464	0.00718	CcSEcCtD
Olmesartan—Malnutrition—Temozolomide—malignant glioma	0.00464	0.00718	CcSEcCtD
Olmesartan—Vision blurred—Carmustine—malignant glioma	0.00452	0.007	CcSEcCtD
Olmesartan—Back pain—Temozolomide—malignant glioma	0.00448	0.00694	CcSEcCtD
Olmesartan—Anaemia—Carmustine—malignant glioma	0.00443	0.00686	CcSEcCtD
Olmesartan—Agitation—Carmustine—malignant glioma	0.00441	0.00683	CcSEcCtD
Olmesartan—Vision blurred—Temozolomide—malignant glioma	0.00437	0.00676	CcSEcCtD
Olmesartan—Ill-defined disorder—Temozolomide—malignant glioma	0.0043	0.00666	CcSEcCtD
Olmesartan—Leukopenia—Carmustine—malignant glioma	0.00429	0.00665	CcSEcCtD
Olmesartan—Anaemia—Temozolomide—malignant glioma	0.00428	0.00663	CcSEcCtD
Olmesartan—Agitation—Temozolomide—malignant glioma	0.00426	0.0066	CcSEcCtD
Olmesartan—Angioedema—Temozolomide—malignant glioma	0.00424	0.00656	CcSEcCtD
Olmesartan—Malaise—Temozolomide—malignant glioma	0.00418	0.00647	CcSEcCtD
Olmesartan—Vertigo—Temozolomide—malignant glioma	0.00416	0.00645	CcSEcCtD
Olmesartan—Leukopenia—Temozolomide—malignant glioma	0.00415	0.00642	CcSEcCtD
Olmesartan—Palpitations—Temozolomide—malignant glioma	0.0041	0.00634	CcSEcCtD
Olmesartan—Myalgia—Carmustine—malignant glioma	0.00408	0.00632	CcSEcCtD
Olmesartan—Chest pain—Carmustine—malignant glioma	0.00408	0.00632	CcSEcCtD
Olmesartan—Anxiety—Carmustine—malignant glioma	0.00407	0.0063	CcSEcCtD
Olmesartan—Cough—Temozolomide—malignant glioma	0.00404	0.00626	CcSEcCtD
Olmesartan—Arthralgia—Temozolomide—malignant glioma	0.00395	0.00611	CcSEcCtD
Olmesartan—Myalgia—Temozolomide—malignant glioma	0.00395	0.00611	CcSEcCtD
Olmesartan—Anxiety—Temozolomide—malignant glioma	0.00393	0.00609	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00392	0.00607	CcSEcCtD
Olmesartan—Oedema—Carmustine—malignant glioma	0.00391	0.00606	CcSEcCtD
Olmesartan—Discomfort—Temozolomide—malignant glioma	0.0039	0.00604	CcSEcCtD
Olmesartan—Infection—Carmustine—malignant glioma	0.00389	0.00602	CcSEcCtD
Olmesartan—Thrombocytopenia—Carmustine—malignant glioma	0.00383	0.00593	CcSEcCtD
Olmesartan—Tachycardia—Carmustine—malignant glioma	0.00382	0.00592	CcSEcCtD
Olmesartan—Oedema—Temozolomide—malignant glioma	0.00378	0.00586	CcSEcCtD
Olmesartan—Anaphylactic shock—Temozolomide—malignant glioma	0.00378	0.00586	CcSEcCtD
Olmesartan—Infection—Temozolomide—malignant glioma	0.00376	0.00582	CcSEcCtD
Olmesartan—Anorexia—Carmustine—malignant glioma	0.00373	0.00578	CcSEcCtD
Olmesartan—Nervous system disorder—Temozolomide—malignant glioma	0.00371	0.00574	CcSEcCtD
Olmesartan—Thrombocytopenia—Temozolomide—malignant glioma	0.0037	0.00574	CcSEcCtD
Olmesartan—Skin disorder—Temozolomide—malignant glioma	0.00367	0.00569	CcSEcCtD
Olmesartan—Hypotension—Carmustine—malignant glioma	0.00366	0.00566	CcSEcCtD
Olmesartan—Hyperhidrosis—Temozolomide—malignant glioma	0.00366	0.00566	CcSEcCtD
Olmesartan—Anorexia—Temozolomide—malignant glioma	0.00361	0.00558	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00357	0.00552	CcSEcCtD
Olmesartan—Insomnia—Carmustine—malignant glioma	0.00354	0.00548	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00345	0.00534	CcSEcCtD
Olmesartan—Insomnia—Temozolomide—malignant glioma	0.00342	0.0053	CcSEcCtD
Olmesartan—Decreased appetite—Carmustine—malignant glioma	0.0034	0.00527	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Carmustine—malignant glioma	0.00338	0.00523	CcSEcCtD
Olmesartan—Pain—Carmustine—malignant glioma	0.00335	0.00518	CcSEcCtD
Olmesartan—Constipation—Carmustine—malignant glioma	0.00335	0.00518	CcSEcCtD
Olmesartan—Dyspepsia—Temozolomide—malignant glioma	0.00333	0.00516	CcSEcCtD
Olmesartan—Decreased appetite—Temozolomide—malignant glioma	0.00329	0.00509	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00327	0.00506	CcSEcCtD
Olmesartan—Fatigue—Temozolomide—malignant glioma	0.00326	0.00505	CcSEcCtD
Olmesartan—Pain—Temozolomide—malignant glioma	0.00323	0.00501	CcSEcCtD
Olmesartan—Constipation—Temozolomide—malignant glioma	0.00323	0.00501	CcSEcCtD
Olmesartan—Feeling abnormal—Carmustine—malignant glioma	0.00323	0.00499	CcSEcCtD
Olmesartan—Gastrointestinal pain—Carmustine—malignant glioma	0.0032	0.00496	CcSEcCtD
Olmesartan—Feeling abnormal—Temozolomide—malignant glioma	0.00312	0.00483	CcSEcCtD
Olmesartan—Abdominal pain—Carmustine—malignant glioma	0.00309	0.00479	CcSEcCtD
Olmesartan—Body temperature increased—Carmustine—malignant glioma	0.00309	0.00479	CcSEcCtD
Olmesartan—Gastrointestinal pain—Temozolomide—malignant glioma	0.00309	0.00479	CcSEcCtD
Olmesartan—Urticaria—Temozolomide—malignant glioma	0.00301	0.00465	CcSEcCtD
Olmesartan—Body temperature increased—Temozolomide—malignant glioma	0.00299	0.00463	CcSEcCtD
Olmesartan—Abdominal pain—Temozolomide—malignant glioma	0.00299	0.00463	CcSEcCtD
Olmesartan—Asthenia—Carmustine—malignant glioma	0.00281	0.00435	CcSEcCtD
Olmesartan—Asthenia—Temozolomide—malignant glioma	0.00271	0.0042	CcSEcCtD
Olmesartan—Diarrhoea—Carmustine—malignant glioma	0.00268	0.00415	CcSEcCtD
Olmesartan—Pruritus—Temozolomide—malignant glioma	0.00268	0.00414	CcSEcCtD
Olmesartan—Dizziness—Carmustine—malignant glioma	0.00259	0.00401	CcSEcCtD
Olmesartan—Diarrhoea—Temozolomide—malignant glioma	0.00259	0.00401	CcSEcCtD
Olmesartan—Dizziness—Temozolomide—malignant glioma	0.0025	0.00387	CcSEcCtD
Olmesartan—Vomiting—Carmustine—malignant glioma	0.00249	0.00385	CcSEcCtD
Olmesartan—Rash—Carmustine—malignant glioma	0.00247	0.00382	CcSEcCtD
Olmesartan—Dermatitis—Carmustine—malignant glioma	0.00247	0.00382	CcSEcCtD
Olmesartan—Headache—Carmustine—malignant glioma	0.00245	0.0038	CcSEcCtD
Olmesartan—Vomiting—Temozolomide—malignant glioma	0.00241	0.00372	CcSEcCtD
Olmesartan—Rash—Temozolomide—malignant glioma	0.00239	0.00369	CcSEcCtD
Olmesartan—Dermatitis—Temozolomide—malignant glioma	0.00238	0.00369	CcSEcCtD
Olmesartan—Headache—Temozolomide—malignant glioma	0.00237	0.00367	CcSEcCtD
Olmesartan—Nausea—Carmustine—malignant glioma	0.00233	0.0036	CcSEcCtD
Olmesartan—Nausea—Temozolomide—malignant glioma	0.00225	0.00348	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCR3—malignant glioma	0.00205	0.00628	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—BDKRB2—malignant glioma	0.0019	0.00582	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—BDKRB2—malignant glioma	0.00188	0.00574	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00187	0.00571	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00185	0.00567	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00182	0.00555	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—KNG1—malignant glioma	0.00173	0.00529	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—KNG1—malignant glioma	0.00171	0.00523	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.0017	0.0052	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IFNG—malignant glioma	0.00169	0.00517	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00166	0.00508	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.00161	0.00492	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—malignant glioma	0.00158	0.00482	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CXCL8—malignant glioma	0.00157	0.0048	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00155	0.00473	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL1B—malignant glioma	0.00151	0.00461	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CASP3—malignant glioma	0.0015	0.0046	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL2—malignant glioma	0.0015	0.00459	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—SLC5A5—malignant glioma	0.00148	0.00453	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—RTEL1—malignant glioma	0.00148	0.00453	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.00147	0.0045	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00145	0.00444	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—malignant glioma	0.00144	0.00439	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCR4—malignant glioma	0.00141	0.00432	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—APOD—malignant glioma	0.00141	0.00432	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—SLC6A3—malignant glioma	0.00141	0.00431	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00138	0.00421	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.00137	0.00419	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00131	0.00399	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.0013	0.00397	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—VEGFA—malignant glioma	0.00128	0.0039	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00126	0.00385	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00124	0.0038	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00122	0.00373	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LATS2—malignant glioma	0.00121	0.00369	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—GSTP1—malignant glioma	0.00119	0.00365	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00119	0.00363	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—malignant glioma	0.00117	0.00359	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00115	0.00351	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—F2—malignant glioma	0.00112	0.00342	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00112	0.00341	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—F2—malignant glioma	0.0011	0.00338	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—TNF—malignant glioma	0.00109	0.00334	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00106	0.00323	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCR3—malignant glioma	0.00105	0.00321	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00104	0.00317	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00102	0.00313	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—APOD—malignant glioma	0.00101	0.00309	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.001	0.00306	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—RTEL1—malignant glioma	0.000995	0.00304	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000975	0.00298	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—BDKRB2—malignant glioma	0.00096	0.00293	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000949	0.0029	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—PDGFB—malignant glioma	0.000944	0.00289	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000941	0.00288	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LATS1—malignant glioma	0.000914	0.00279	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000878	0.00268	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—KNG1—malignant glioma	0.000873	0.00267	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—COX8A—malignant glioma	0.00085	0.0026	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000835	0.00255	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR4—malignant glioma	0.000798	0.00244	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.000779	0.00238	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00076	0.00232	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.000752	0.0023	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.000741	0.00227	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR4—malignant glioma	0.000725	0.00222	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ASMT—malignant glioma	0.000723	0.00221	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000723	0.00221	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000711	0.00217	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000707	0.00216	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000688	0.0021	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—BCAN—malignant glioma	0.00068	0.00208	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000664	0.00203	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000632	0.00193	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MDK—malignant glioma	0.000618	0.00189	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCR3—malignant glioma	0.000593	0.00181	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DTX1—malignant glioma	0.000589	0.0018	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—COX8A—malignant glioma	0.000571	0.00175	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—F2—malignant glioma	0.000564	0.00173	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—IDH2—malignant glioma	0.000548	0.00168	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—BDKRB2—malignant glioma	0.000542	0.00166	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCR3—malignant glioma	0.000539	0.00165	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.000522	0.0016	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000517	0.00158	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000517	0.00158	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.000515	0.00158	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2B6—malignant glioma	0.000515	0.00157	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000511	0.00156	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.0005	0.00153	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—KNG1—malignant glioma	0.000493	0.00151	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—BDKRB2—malignant glioma	0.000493	0.00151	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.000487	0.00149	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ASMT—malignant glioma	0.000486	0.00148	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000486	0.00148	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000475	0.00145	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000475	0.00145	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—IDH1—malignant glioma	0.000471	0.00144	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SUFU—malignant glioma	0.000468	0.00143	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HEY2—malignant glioma	0.000462	0.00141	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BCAN—malignant glioma	0.000457	0.0014	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SPHK1—malignant glioma	0.000456	0.00139	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000452	0.00138	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GFAP—malignant glioma	0.000452	0.00138	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KNG1—malignant glioma	0.000448	0.00137	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.000447	0.00137	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP2C18—malignant glioma	0.000447	0.00137	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000446	0.00136	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SPHK1—malignant glioma	0.000437	0.00134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HEY1—malignant glioma	0.000428	0.00131	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR4—malignant glioma	0.000428	0.00131	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000424	0.0013	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000421	0.00129	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIST1H3B—malignant glioma	0.000416	0.00127	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—malignant glioma	0.000398	0.00122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MMP3—malignant glioma	0.000397	0.00121	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000384	0.00117	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JAG2—malignant glioma	0.00038	0.00116	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00037	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—IDH2—malignant glioma	0.000368	0.00113	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTT1—malignant glioma	0.000361	0.0011	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000347	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2B6—malignant glioma	0.000346	0.00106	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS1—malignant glioma	0.000339	0.00103	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000337	0.00103	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—H3F3A—malignant glioma	0.000321	0.000982	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2—malignant glioma	0.000319	0.000975	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCR3—malignant glioma	0.000318	0.000973	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—IDH1—malignant glioma	0.000317	0.000968	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—BCHE—malignant glioma	0.000315	0.000962	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC5A5—malignant glioma	0.000311	0.00095	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NTRK2—malignant glioma	0.000309	0.000946	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—YWHAE—malignant glioma	0.000309	0.000946	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FLT1—malignant glioma	0.000308	0.000942	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—DUSP6—malignant glioma	0.000307	0.000938	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SPHK1—malignant glioma	0.000306	0.000936	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000305	0.000933	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JAG1—malignant glioma	0.000303	0.000926	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH3—malignant glioma	0.000302	0.000922	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP2C18—malignant glioma	0.0003	0.000917	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FBXW7—malignant glioma	0.000297	0.000907	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000294	0.000899	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000291	0.00089	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BDKRB2—malignant glioma	0.000291	0.000889	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2—malignant glioma	0.00029	0.000885	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000286	0.000875	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000283	0.000865	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT2—malignant glioma	0.000279	0.000854	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CG—malignant glioma	0.000277	0.000847	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PTPN11—malignant glioma	0.000272	0.000832	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH2—malignant glioma	0.00027	0.000827	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000268	0.00082	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KNG1—malignant glioma	0.000265	0.000809	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000258	0.000788	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000254	0.000777	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT2—malignant glioma	0.000254	0.000775	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NTRK1—malignant glioma	0.000252	0.000771	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GSTP1—malignant glioma	0.00025	0.000765	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000249	0.000761	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CD—malignant glioma	0.000244	0.000745	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAT—malignant glioma	0.000244	0.000745	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTT1—malignant glioma	0.000243	0.000742	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP3—malignant glioma	0.000235	0.000717	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000234	0.000715	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN2B—malignant glioma	0.000232	0.000711	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NCOR1—malignant glioma	0.00023	0.000703	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS1—malignant glioma	0.000227	0.000695	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000227	0.000693	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTK2—malignant glioma	0.000226	0.00069	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—malignant glioma	0.000225	0.000687	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HES1—malignant glioma	0.000222	0.000678	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCOR1—malignant glioma	0.000221	0.000674	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RAF1—malignant glioma	0.000218	0.000665	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—malignant glioma	0.000215	0.000657	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000212	0.000649	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BCHE—malignant glioma	0.000211	0.000646	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDGFRA—malignant glioma	0.000211	0.000646	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC5A5—malignant glioma	0.000209	0.000638	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SPP1—malignant glioma	0.000205	0.000627	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000205	0.000626	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—malignant glioma	0.000204	0.000624	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000198	0.000604	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000196	0.000598	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—malignant glioma	0.000195	0.000596	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TERT—malignant glioma	0.000194	0.000594	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000192	0.000588	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDGFB—malignant glioma	0.00019	0.00058	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGFR1—malignant glioma	0.000189	0.000577	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CAV1—malignant glioma	0.000188	0.000573	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIF1A—malignant glioma	0.000186	0.000568	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CAV1—malignant glioma	0.00018	0.00055	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000179	0.000548	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KDR—malignant glioma	0.000178	0.000543	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2—malignant glioma	0.000171	0.000523	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FN1—malignant glioma	0.000171	0.000523	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CG—malignant glioma	0.000171	0.000522	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000171	0.000522	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BAD—malignant glioma	0.000169	0.000517	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GSTP1—malignant glioma	0.000168	0.000514	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH1—malignant glioma	0.000167	0.000512	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—malignant glioma	0.000165	0.000504	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CD80—malignant glioma	0.000164	0.000501	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CG—malignant glioma	0.000164	0.000501	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APC—malignant glioma	0.000164	0.000501	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAT—malignant glioma	0.000164	0.0005	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGF—malignant glioma	0.000162	0.000495	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTPN11—malignant glioma	0.000161	0.000492	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NCOR1—malignant glioma	0.000155	0.000473	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BRAF—malignant glioma	0.000154	0.00047	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CD—malignant glioma	0.00015	0.000459	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT2—malignant glioma	0.00015	0.000458	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—malignant glioma	0.000149	0.000456	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CD—malignant glioma	0.000144	0.00044	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000143	0.000436	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KRAS—malignant glioma	0.000141	0.000431	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF2—malignant glioma	0.000138	0.000421	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CB—malignant glioma	0.000131	0.0004	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—malignant glioma	0.00013	0.000397	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CA—malignant glioma	0.000129	0.000396	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MDM2—malignant glioma	0.000129	0.000394	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RAF1—malignant glioma	0.000129	0.000393	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB2—malignant glioma	0.000127	0.000389	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CAV1—malignant glioma	0.000126	0.000385	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CB—malignant glioma	0.000125	0.000384	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—malignant glioma	0.000121	0.000369	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.00012	0.000368	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—malignant glioma	0.000116	0.000356	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—malignant glioma	0.000115	0.000353	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—malignant glioma	0.000115	0.000352	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CG—malignant glioma	0.000115	0.000351	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTEN—malignant glioma	0.000113	0.000346	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—malignant glioma	0.000111	0.000339	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—malignant glioma	0.000109	0.000333	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTEN—malignant glioma	0.000108	0.000331	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—malignant glioma	0.000106	0.000323	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CD—malignant glioma	0.000101	0.000309	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—malignant glioma	9.79e-05	0.000299	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—malignant glioma	9.7e-05	0.000296	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MYC—malignant glioma	9.01e-05	0.000275	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—malignant glioma	8.81e-05	0.000269	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CB—malignant glioma	8.8e-05	0.000269	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—malignant glioma	8.72e-05	0.000266	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KRAS—malignant glioma	8.32e-05	0.000254	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CA—malignant glioma	7.98e-05	0.000244	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CA—malignant glioma	7.65e-05	0.000234	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTEN—malignant glioma	7.6e-05	0.000232	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—malignant glioma	7.4e-05	0.000226	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—malignant glioma	6.52e-05	0.000199	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—malignant glioma	6.25e-05	0.000191	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CA—malignant glioma	5.36e-05	0.000164	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—malignant glioma	4.38e-05	0.000134	CbGpPWpGaD
